GlobeNewswire Inc.··Catalyst Pharmaceuticals, Inc.Catalyst Pharma Secures Patent Protection for FIRDAPSE Through 2035 Settlement
Catalyst Pharma settles patent litigation with Hetero Labs, blocking generic FIRDAPSE entry until 2035. Fourth major competitor settlement extends exclusivity.
CPRXrare diseasepatent settlement